Role of Exosomal Competitive Endogenous RNA (ceRNA) in Diagnosis and Treatment of Malignant Tumors

Overview

Journal Bioengineered

Date 2022 May 16

PMID 35577352

Authors

Mingwen Mao

Jingyu Zhang

Yizhen Xiang

Mengdan Gong

Yongqin Deng

Dong Ye

Affiliations

Soon will be listed here.

Abstract

Malignant tumors are a threat to human health, thus it is critical to better understand the mechanism of tumor occurrence and development and to find key therapeutic targets. Competitive endogenous RNA (ceRNA) is a type of RNA molecule that includes mRNA of coding-protein, pseudogenes, long non-coding RNA (lncRNA), and circular RNA (circRNA) etc. It is created through a competitive combination of common small RNA (miRNA) and has an inhibitory effect on mRNA translation. ceRNA regulate the post transcriptional expression of genes by competitively binding to common microRNAs (miRNAs).Studies have shown that cernas are involved in tumor cell proliferation, invasion and migration, drug resistance, angiogenesis, as well as tumor immunity, and so on, affecting the progression of tumor development. This article reviews the reported roles of exosomal ceRNA in the diagnosis and treatment of malignant tumors and the mechanisms underlying these.

Citing Articles

Exosomal lncRNAs as diagnostic and therapeutic targets in multiple myeloma.

Yan H, Jiang N, Li X, Lin C, Wang F, Zhang J Front Oncol. 2025; 14:1522491.

PMID: 39886670 PMC: 11779718. DOI: 10.3389/fonc.2024.1522491.

Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.

Zhang Y, Lun H, Zhu N, Yang N, Ding K, Chen B Front Oncol. 2025; 14():1485605.

PMID: 39850812 PMC: 11754200. DOI: 10.3389/fonc.2024.1485605.

Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy.

To K, Zhang H, Cho W Cancer Drug Resist. 2024; 7:37.

PMID: 39403602 PMC: 11472581. DOI: 10.20517/cdr.2024.66.

Circular RNAs in human diseases.

Wang Y, Zhang J, Yang Y, Liu Z, Sun S, Li R MedComm (2020). 2024; 5(9):e699.

PMID: 39239069 PMC: 11374765. DOI: 10.1002/mco2.699.

Exploring the evolving roles and clinical significance of circRNAs in head and neck squamous cell carcinoma.

Lei P, Guo Q, Hao J, Liu H, Chen Y, Wu F J Cancer. 2024; 15(12):3984-3994.

PMID: 38911371 PMC: 11190751. DOI: 10.7150/jca.96614.

References

Huang H, Tang X, Huang X, Zhou L, Hao Y, Zheng Y . Long noncoding RNA LINC00511 promoted cell proliferation and invasion via regulating miR-124-3p/EZH2 pathway in gastric cancer. Eur Rev Med Pharmacol Sci. 2020; 24(8):4232-4245. DOI: 10.26355/eurrev_202004_21003. View

Sun C, Wang H, Han X, Liu Y, Wang M, Zhang H . LINC00511 promotes gastric cancer cell growth by acting as a ceRNA. World J Gastrointest Oncol. 2020; 12(4):394-404. PMC: 7191338. DOI: 10.4251/wjgo.v12.i4.394. View

Luan Y, Li X, Luan Y, Zhao R, Li Y, Liu L . Circulating lncRNA UCA1 Promotes Malignancy of Colorectal Cancer via the miR-143/MYO6 Axis. Mol Ther Nucleic Acids. 2020; 19:790-803. PMC: 6970172. DOI: 10.1016/j.omtn.2019.12.009. View

Barbagallo C, Brex D, Caponnetto A, Cirnigliaro M, Scalia M, Magnano A . LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions. Mol Ther Nucleic Acids. 2018; 12:229-241. PMC: 6023947. DOI: 10.1016/j.omtn.2018.05.009. View

Lei B, Qi W, Zhao Y, Li Y, Liu S, Xu X . PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma. Hum Pathol. 2014; 46(2):217-24. DOI: 10.1016/j.humpath.2014.07.026. View

Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z . Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 2019; 18(1):20. PMC: 6360801. DOI: 10.1186/s12943-018-0935-5. View

Wang Y, Wang H, Zheng R, Wu P, Sun Z, Chen J . Circular RNA ITCH suppresses metastasis of gastric cancer via regulating miR-199a-5p/Klotho axis. Cell Cycle. 2021; 20(5-6):522-536. PMC: 8018440. DOI: 10.1080/15384101.2021.1878327. View

Li D, Xu M, Wang Z, Huang P, Huang C, Chen Z . The EMT-induced lncRNA NR2F1-AS1 positively modulates NR2F1 expression and drives gastric cancer via miR-29a-3p/VAMP7 axis. Cell Death Dis. 2022; 13(1):84. PMC: 8791943. DOI: 10.1038/s41419-022-04540-2. View

Zhao J, Li L, Han Z, Wang Z, Qin L . Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis. Am J Cancer Res. 2019; 9(7):1367-1381. PMC: 6682713. View

10.

Chi H, Yang R, Zheng X, Zhang L, Jiang R, Chen J . LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer. Int J Mol Sci. 2018; 19(9). PMC: 6163378. DOI: 10.3390/ijms19092531. View

11.

Wang F, Cao C, Han K, Zhao Y, Cai M, Xiang Z . APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production. J Clin Invest. 2018; 129(2):727-743. PMC: 6355227. DOI: 10.1172/JCI122478. View

12.

Niu Y, Bao L, Chen Y, Wang C, Luo M, Zhang B . HIF2-Induced Long Noncoding RNA RAB11B-AS1 Promotes Hypoxia-Mediated Angiogenesis and Breast Cancer Metastasis. Cancer Res. 2020; 80(5):964-975. PMC: 7056556. DOI: 10.1158/0008-5472.CAN-19-1532. View

13.

Sheng Z, Wang X, Xu G, Shan G, Chen L . Analyses of a Panel of Transcripts Identified From a Small Sample Size and Construction of RNA Networks in Hepatocellular Carcinoma. Front Genet. 2019; 10:431. PMC: 6530380. DOI: 10.3389/fgene.2019.00431. View

14.

Ma R, Ye X, Cheng H, Cui H, Chang X . Tumor-derived exosomal circRNA051239 promotes proliferation and migration of epithelial ovarian cancer. Am J Transl Res. 2021; 13(3):1125-1139. PMC: 8014378. View

15.

Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan Y . circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020; 11(1):32. PMC: 6965119. DOI: 10.1038/s41419-020-2230-9. View

16.

Luo X, Wei J, Yang F, Pang X, Shi F, Wei Y . Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis. Cancer Cell Int. 2019; 19:323. PMC: 6889431. DOI: 10.1186/s12935-019-1042-4. View

17.

Wei B, Kong W, Mou X, Wang S . Comprehensive analysis of tumor immune infiltration associated with endogenous competitive RNA networks in lung adenocarcinoma. Pathol Res Pract. 2018; 215(1):159-170. DOI: 10.1016/j.prp.2018.10.032. View

18.

Yang S, Wang D, Zhou S, Zhang Q, Wang J, Zhong S . Identification of circRNA-miRNA networks for exploring an underlying prognosis strategy for breast cancer. Epigenomics. 2020; 12(2):101-125. DOI: 10.2217/epi-2019-0058. View

19.

Chen X, Wang Z, Tong F, Dong X, Wu G, Zhang R . lncRNA UCA1 Promotes Gefitinib Resistance as a ceRNA to Target FOSL2 by Sponging miR-143 in Non-small Cell Lung Cancer. Mol Ther Nucleic Acids. 2020; 19:643-653. PMC: 6965519. DOI: 10.1016/j.omtn.2019.10.047. View

20.

Nie D, Fu J, Chen H, Cheng J, Fu J . Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential. Int J Mol Sci. 2019; 20(4). PMC: 6413055. DOI: 10.3390/ijms20040861. View